Skip to main content

Spectrum: Autism Research News

Tag: fragile X syndrome

July 2017

Diabetes drug eases fragile X features in mice

by  /  3 July 2017

A drug used to treat type 2 diabetes reverses behavioral and brain abnormalities in a mouse model of fragile X syndrome.

Comments
June 2017

Tube test tracks social behavior in mice

by  /  30 June 2017

Measuring how long a mouse cozies up with a cagemate in a tiny tube can help to detect social impairments in mice.

Comments

Why it’s time to spin autism genes into drug screens

by  /  27 June 2017

Autism researchers’ top priority should be shifting their focus to finding treatments for severe forms of the condition.

Comments
Week of JuneJun
19th
2017

Fathering geeks; GWAS weaknesses; Prozac protection and more

by  /  23 June 2017

Paternal age drives ‘geek index’ scores, GWAS may have a big weakness, serotonin boosts mouse social behaviors, and what is science Tinder?

Comments
April 2017

Mighty element plays major part in autism

by ,  /  18 April 2017

Probing the function of a protein in a calcium signaling pathway may lead to a diagnostic test for autism and a path toward treatments.

Comments
March 2017
Four white mice bike ahead of a white rat, who is juggling on a unicycle; suggesting that rats can do more for research than mice.

Meet the newest contestant in the scientific rat race

by  /  15 March 2017

Mice have long been the mainstay of autism research, but a small group of scientists say rats are the superior choice. Rats are bigger, smarter, friendlier — and a lot more fun.

Comments

Autism experts see benefits to tweaking drug approval process

by  /  13 March 2017

Many researchers oppose unfettered deregulation of the drug approval process, but welcome more relaxed rules for clinical trials.

Comments
illustration of person with autism struggling with addiction

Autism’s hidden habit

by  /  1 March 2017

Conventional wisdom holds that people with autism don’t get hooked on alcohol or other drugs, but new evidence suggests otherwise.

Comments
February 2017
Several arrows have fallen short of their target, which is a pill on a bullseye. This image suggests that a drug targeted towards autism's symptoms has not yet been made.

Why don’t we have better drugs for autism?

by  /  15 February 2017

Clinical trials for autism drugs have been plagued with problems: bad design, the wrong measures, too broad a range of participants. All that is finally starting to change.

Comments

Autism, fragile X follow different developmental paths

by  /  1 February 2017

Children with autism show an increase in restricted interests in their preteen years that is not seen in those with fragile X syndrome.

Comments